BERLIN (Reuters) - Shares in genetic testing company Qiagen (QIA.DE) rose 3.6% on Monday after a report that the firm was talking to an interested party about a possible acquisition.
On Friday, the CTFN website cited an unnamed industry executive as saying Qiagen was in talks about a possible takeover.
A Qiagen spokesman declined to comment on the report.
In December, shares in Qiagen plunged after the company said it had decided against a sale as it saw continuing to be a stand-alone business as the best option, terminating all discussions and saying they were not compelling.
Reporting by Emma Thomasson; Editing by Riham Alkousaa